Literature DB >> 25715405

Chronic exposure to IFNα drives medullar lymphopoiesis towards T-cell differentiation in mice.

Marianna Di Scala1, Irene Gil-Fariña1, Lucia Vanrell1, Rodrigo Sánchez-Bayona1, Diego Alignani2, Cristina Olagüe1, Africa Vales1, Pedro Berraondo1, Jesús Prieto3, Gloria González-Aseguinolaza4.   

Abstract

Interferon-α is a potent antiviral agent and a vigorous adjuvant in the induction of T-cell responses but its use is limited by hematologic toxicity. Interferon-α alters hematopoietic stem cell dormancy and impairs myelocytic and erythrocytic/megakaryocytic differentiation from hematopoietic progenitors. However, the effect of chronic interferon-α exposure on hematopoietic precursors has still not been well characterized. Here, we transduced the liver of mice with an adenoassociated vector encoding interferon-α to achieve sustained high serum levels of the cytokine. The bone marrow of these animals showed diminished long-term and short-term hematopoietic stem cells, reduction of multipotent progenitor cells, and marked decrease of B cells, but significant increase in the proportion of CD8(+) and CD4(+)CD8(+) T cells. Upon adoptive transfer to RAG(-/-) mice, bone marrow cells from interferon-α-treated animals generated CD4(+) and CD8(+) T cells while CD19(+), CD11b(+) and NK1.1(+) lineages failed to develop. These effects are associated with the transcriptional downregulation of transcription factors involved in B-cell differentiation and modulation of key factors for T-cell development. Thus, sustained interferon-α exposure causes hematopoietic stem cells exhaustion and drives common lymphoid progenitors towards T-cell generation. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25715405      PMCID: PMC5004416          DOI: 10.3324/haematol.2014.115410

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  37 in total

1.  Awakening dormant haematopoietic stem cells.

Authors:  Andreas Trumpp; Marieke Essers; Anne Wilson
Journal:  Nat Rev Immunol       Date:  2010-03       Impact factor: 53.106

Review 2.  Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy.

Authors:  Ching-Lung Lai; Man-Fung Yuen
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

3.  Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus.

Authors:  D Binder; J Fehr; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

4.  IFNalpha activates dormant haematopoietic stem cells in vivo.

Authors:  Marieke A G Essers; Sandra Offner; William E Blanco-Bose; Zoe Waibler; Ulrich Kalinke; Michel A Duchosal; Andreas Trumpp
Journal:  Nature       Date:  2009-02-11       Impact factor: 49.962

Review 5.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

Review 6.  IFN-α in the treatment of melanoma.

Authors:  Ahmad A Tarhini; Helen Gogas; John M Kirkwood
Journal:  J Immunol       Date:  2012-10-15       Impact factor: 5.422

7.  Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus.

Authors:  Arumugam Palanichamy; Jason W Bauer; Srilakshmi Yalavarthi; Nida Meednu; Jennifer Barnard; Teresa Owen; Christopher Cistrone; Anna Bird; Alfred Rabinovich; Sarah Nevarez; Jason S Knight; Russell Dedrick; Alexander Rosenberg; Chungwen Wei; Javier Rangel-Moreno; Jane Liesveld; Inaki Sanz; Emily Baechler; Mariana J Kaplan; Jennifer H Anolik
Journal:  J Immunol       Date:  2013-12-30       Impact factor: 5.422

8.  Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ.

Authors:  Christian Schürch; Carsten Riether; Michael A Amrein; Adrian F Ochsenbein
Journal:  J Exp Med       Date:  2013-02-11       Impact factor: 14.307

9.  The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin 7.

Authors:  Juli P Miller; David Izon; William DeMuth; Rachel Gerstein; Avinash Bhandoola; David Allman
Journal:  J Exp Med       Date:  2002-09-02       Impact factor: 14.307

Review 10.  IFNα Inducible Models of Murine SLE.

Authors:  Zheng Liu; Anne Davidson
Journal:  Front Immunol       Date:  2013-10-02       Impact factor: 7.561

View more
  6 in total

1.  Immunomodulatory and direct activities of ropeginterferon alfa-2b on cancer cells in mouse models of leukemia.

Authors:  Kazuki Sakatoku; Yasuhiro Nakashima; Joji Nagasaki; Mitsutaka Nishimoto; Asao Hirose; Mika Nakamae; Hideo Koh; Masayuki Hino; Hirohisa Nakamae
Journal:  Cancer Sci       Date:  2022-05-02       Impact factor: 6.518

2.  Identification of IFN-γ-producing T cells as the main mediators of the side effects associated to mouse interleukin-15 sustained exposure.

Authors:  Marianna Di Scala; Irene Gil-Fariña; Cristina Olagüe; Africa Vales; Luciano Sobrevals; Puri Fortes; David Corbacho; Gloria González-Aseguinolaza
Journal:  Oncotarget       Date:  2016-08-02

3.  The bacterial microbiota regulates normal hematopoiesis via metabolite-induced type 1 interferon signaling.

Authors:  Hannah Yan; Forrest C Walker; Arushana Ali; Hyojeong Han; Lin Tan; Lucas Veillon; Philip L Lorenzi; Megan T Baldridge; Katherine Y King
Journal:  Blood Adv       Date:  2022-03-22

Review 4.  Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output.

Authors:  Maria Fernanda Pascutti; Martje N Erkelens; Martijn A Nolte
Journal:  Front Immunol       Date:  2016-09-16       Impact factor: 7.561

5.  Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice.

Authors:  Marianna Di Scala; Itziar Otano; Irene Gil-Fariña; Lucia Vanrell; Mirja Hommel; Cristina Olagüe; Africa Vales; Miguel Galarraga; Laura Guembe; Carlos Ortiz de Solorzano; Indrajit Ghosh; Mala K Maini; Jesús Prieto; Gloria González-Aseguinolaza
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

6.  Targeting transgenic proteins to alpha granules for platelet-directed gene therapy.

Authors:  Vanessa M A Woods; Lisette J Latorre-Rey; Franziska Schenk; Marcel G E Rommel; Thomas Moritz; Ute Modlich
Journal:  Mol Ther Nucleic Acids       Date:  2022-01-03       Impact factor: 8.886

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.